The experimental drug, called daraxonrasib, does not cure pancreatic cancer, which is one of the deadliest and most difficult ...

An experimental once-daily pill roughly doubled how long patients with previously treated advanced pancreatic cancer lived in ...

A once-daily pill is giving late-stage pancreatic cancer patients something the disease has rarely offered them: more time.

Fast-growing Revolution Medicines preps potential launch of cutting-edge pancreatic cancer drug ...

Add Yahoo as a preferred source to see more of our stories on Google. A new pancreatic cancer pill drew a standing ovation that lasted nearly a minute from oncologists at the world's largest cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: iStock After years of fruitless efforts to block a key genetic force behind pancreatic cancer, researchers say an ...

Cancer researchers got a rare standing ovation at this year’s American Society of Clinical Oncology meeting in Chicago, and it was for a cancer that’s resisted real progress for decades. The drug is ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. "While not ...

Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts cancer cells' ability to survive ...

Cancer cells have a voracious appetite for sugar—using it to fuel their rapid growth. This is why many scientists have tried ...